Sowell Financial Services’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-104
Closed -$15K 2560
2021
Q1
$15K Buy
104
+95
+1,056% +$16.4K ﹤0.01% 2172
2020
Q4
$1K Buy
9
+3
+50% +$435 ﹤0.01% 2627
2020
Q3
$1K Buy
+6
New +$630 ﹤0.01% 2440

Other funds holding TXG

Sowell Financial Services's TXG Position: Q2 2021 in Review

Sowell Financial Services sold out of 10x Genomics (TXG) in Q2 2021, closing a stake of 104 shares — an estimated $15K sold.

Sowell Financial Services first reported a position in TXG in Q3 2020 and held it in 3 quarters. The position peaked at $15K in Q1 2021. 341 funds tracked by Wall St. Rank hold TXG as of Q2 2021.

  • Sowell Financial Services reported no remaining 10x Genomics position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 104 10x Genomics shares in Q2 2021, an estimated $15K.
  • Sowell Financial Services first reported a position in 10x Genomics in Q3 2020 and held it in 3 quarters.
  • Sowell Financial Services's 10x Genomics position peaked at $15K in Q1 2021.
  • 341 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.